SCHEMBL7096949

SCHEMBL7096949

CC(C)(C)C(=O)OCCN

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
GAA P10253 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PRKCA P17252 2/20 0.41
MAPT P10636 2/20 0.33
ALDH1A1 P00352 2/20 0.33
THRB P10828 1/20 0.33
CNR1 P21554 1/20 0.33
ELANE P08246 3/20 0.32
CYP1A2 P05177 1/20 0.32
IDO1 P14902 1/20 0.32
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31
MEN1 O00255 1/20 0.31
GBA1 P04062 1/20 0.31
RECQL P46063 1/20 0.31
KMT2A Q03164 1/20 0.31
BTN3A1 O00481 2/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3506265 0.98 POLB (0.42) POLBGAANPSR1PRKCAMAPT
Tromethamine SCHEMBL3189166 0.88 MEN1 (0.39) POLBGAANPSR1PRKCACYP4F2
SCHEMBL12392870 0.87 POLB (0.39) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL12972547 0.86 NPSR1 (0.41) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL12209931 0.85 DGAT1 (0.34) POLBGAANPSR1MAPTALDH1A1
SCHEMBL13089654 0.84 NPSR1 (0.40) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL4258156 0.84 POLB (0.48) POLBGAANPSR1PRKCAMAPT
SCHEMBL18274690 0.83 ALDH1A1 (0.35) POLBGAANPSR1MAPTALDH1A1
SCHEMBL12165302 0.82 PAOX (0.40) POLBGAANPSR1PRKCAALDH1A1
SCHEMBL19707972 0.81 ALDH1A1 (0.31) POLBGAANPSR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103865013-A Preparation method of glucose and temperature-responsive insulin controlled release carrier UNIV TONGJI 2014-06-18 CN claimed
CN-115044040-B Polyimide-containing polymer, positive photosensitive resin composition, negative photosensitive resin composition, and pattern forming method 信越化学工业株式会社 2024-07-02 CN disclosed
US-12017994-B2 Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrhea SYMBERIX, INC. (US) 2024-06-25 US disclosed
US-12017994-B2 Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrhea SYMBERIX, INC. (US) 2024-06-25 US disclosed
CN-113527101-B Novel compound, polymer, process for producing the same, photosensitive resin composition, pattern forming process, cured film, and electronic component 信越化学工业株式会社 2024-04-23 CN disclosed
CN-111381447-B Photosensitive resin composition, laminate, and pattern forming method 信越化学工业株式会社 2024-03-08 CN disclosed
CN-109388023-B Photosensitive resin composition, photosensitive resin coating, photosensitive dry film, laminate, and pattern forming method 信越化学工业株式会社 2023-12-22 CN disclosed
US-11767337-B2 Antiviral compounds GILEAD SCIENCES, INC. (US) 2023-09-26 US disclosed
US-20230295201-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2023-09-21 US disclosed
CN-109388022-B Silicone-structure-containing polymer, photosensitive resin composition, photosensitive resin coating layer, photosensitive dry film, laminate, and pattern forming method 信越化学工业株式会社 2023-07-28 CN disclosed
US-6670498-B2 Norbornene and dimethanonaphthalenes substituted with a branched or cyclic tertiary alkoxycarbonyl hydrocarbyleneoxycarbonyl group SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-12-30 US disclosed
US-20030088115-A1 Novel ester compounds, polymers, resist compositions and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2003-05-08 US disclosed
US-20020004178-A1 Novel ester compounds, polymers, resist compositions and patterning process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2002-01-10 US disclosed
EP-0542411-B1 TETRAHYDROTHIENOPYRIDINE DERIVATIVES, FURO AND PYRROLO ANALOGS THEREOF AND THEIR PREPARATION AND USES FOR INHIBITING BLOOD PLATELET AGGREGATION SANKYO CO (JP) 1998-08-12 EP disclosed
US-5691319-A ANTICARCINOGENIC AGENTS SANKYO COMPANY, LIMITED (JP) 1997-11-25 US disclosed
EP-0536936-B1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use SANKYO CO (JP) 1996-08-14 EP disclosed
US-5436242-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation SANKYO COMPANY, LIMITED (JP) 1995-07-25 US disclosed
US-5288726-A Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation UBE INDUSTRIES LIMITED (JP) 1994-02-22 US disclosed
EP-0542411-A2 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation Sankyo Company Limited (JP) 1993-05-19 EP disclosed
EP-0536936-A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use Sankyo Company Limited (JP) 1993-04-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295201-A1 ANTIVIRAL COMPOUNDS MAVS, HAVCR2, ZC3HAV1 POLB 4269/4885GAA 1743/4885NPSR1 1383/4885
US-12017994-B2 Compounds, compositions, and methods for selectively inhibiting β-glucuronidases and alleviating side effects associated with drug treatment induced diarrhea GUSB, SI, ENGASE POLB 2485/4885GAA 5/4885NPSR1 2558/4885
US-11767337-B2 Antiviral compounds MAVS, HAVCR2, ZC3HAV1 POLB 4269/4885GAA 1743/4885NPSR1 1383/4885
US-20030088115-A1 Novel ester compounds, polymers, resist compositions and patterning process RER1, ARCN1, H1-0 POLB 522/4885GAA 4175/4885NPSR1 3950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.